Arecor Therapeutics PLC (GB:AREC) has released an update.
Arecor Therapeutics PLC invites investors to a live presentation of their interim results for the first half of 2024, with CEO Sarah Howell speaking on the Investor Meet Company platform on October 3rd. The event will feature a Q&A session, encouraging both current and potential shareholders to engage and submit questions. The company emphasizes its commitment to enhancing patient care through its proprietary Arestat technology and a robust portfolio of diabetes and other therapeutic products.
For further insights into GB:AREC stock, check out TipRanks’ Stock Analysis page.
